Paralytics in critical care: Not always the bad guy

Current Opinion in Critical Care

Volumn 15, Issue 1, 2009, Pages 59-66

  Forel, Jean Marie ^a   Roch, Antoine ^a   Papazian, Laurent ^a,b  

^a ASSISTANCE PUBLIQUE HÔPITAUX DE MARSEILLE   (France)

^b HÔPITAL SAINTE MARGUERITE   (France)

Author keywords

Acute respiratory failure; Mechanical ventilation; Neuromuscular blocking agents; Pulmonary gas exchange; Respiratory mechanics

Indexed keywords

ATRACURIUM; CISATRACURIUM; INTERLEUKIN 1BETA; INTERLEUKIN 6; INTERLEUKIN 8; MIVACURIUM; NEUROMUSCULAR BLOCKING AGENT; PANCURONIUM; ROCURONIUM; SUXAMETHONIUM; VECURONIUM;

ACUTE LUNG INJURY; ACUTE RESPIRATORY FAILURE; ADULT RESPIRATORY DISTRESS SYNDROME; ANAPHYLAXIS; ARTIFICIAL VENTILATION; ASTHMATIC STATE; ATELECTASIS; BOLUS INJECTION; BREATHING MECHANICS; CONTINUOUS INFUSION; DRUG EFFECT; DRUG INDICATION; DRUG UTILIZATION; ENDOTRACHEAL INTUBATION; FLUSHING; HEART ARRHYTHMIA; HUMAN; HYPOTENSION; HYPOXEMIA; INFLAMMATION; LUNG GAS EXCHANGE; MALIGNANT HYPERTHERMIA; NEUROMUSCULAR DISEASE; OXYGENATION; PARALYSIS; POSITIVE END EXPIRATORY PRESSURE; REVIEW; SEDATION; SEIZURE; SIDE EFFECT; SINGLE DRUG DOSE; TREATMENT OUTCOME;

CRITICAL CARE; HUMANS; INTENSIVE CARE UNITS; NEUROMUSCULAR BLOCKING AGENTS; OUTCOME ASSESSMENT (HEALTH CARE); PULMONARY GAS EXCHANGE; RESPIRATORY DISTRESS SYNDROME, ADULT; RESPIRATORY MECHANICS;

EID: 61449219064     PISSN: 10705295     EISSN: 15317072     Source Type: Journal    
DOI: 10.1097/MCC.0b013e3283220e60     Document Type: Review

References (61)

1. Kress JP, Pohlman AS, O'Connor MF, Hall JB. Daily interruption of sedative infusions in critically ill patients undergoing mechanical ventilation. N Engl J Med 2000; 342:1471-1477.
2. Vender JS, Szokol JW, Murphy GS, Nitsun M. Sedation, analgesia, and neuromuscular blockade in sepsis: an evidence-based review. Crit Care Med 2004; 32:3554-3561.
3. Hedenstierna G, Strandberg A, Brismar B, et al. Functional residual capacity, thoracoabdominal dimensions, and central blood volume during general anesthesia with muscle paralysis and mechanical ventilation. Anesthesiology 1985; 62:247-254.
4. Murray MJ, Cowen J, DeBlock H, et al. Clinical practice guidelines for sustained neuromuscular blockade in the adult critically ill patient. Crit Care Med 2002; 30:142-156.
5. The Acute Respiratory Distress Syndrome Network. Ventilation with lower tidal volumes as compared with traditional tidal volumes for acute lung injury and the acute respiratory distress syndrome. N Engl J Med 2000; 342:1301-1308.
6. Hansen-Flaschen JH, Brazinsky S, Basile C, Lanken PN. Use of sedating drugs and neuromuscular blocking agents in patients requiring mechanical ventilation for respiratory failure. A national survey. JAMA 1991; 266:2870-2875.
7. Rhoney DH, Murry KR. National survey of the use of sedating drugs, neuromuscular blocking agents, and reversal agents in the intensive care unit. J Intensive Care Med 2003; 18:139-145.
8. Christensen BV, Thunedborg LP. Use of sedatives, analgesics and neuromuscular blocking agents in Danish ICUs 1996/97. A national survey. Intensive Care Med 1999; 25:186-191.
9. Samuelson KA, Larsson S, Lundberg D, Fridlund B. Intensive care sedation of mechanically ventilated patients: a national Swedish survey. Intensive Crit Care Nurs 2003; 19:350-362.
10. Arroliga A, Frutos-Vivar F, Hall J, et al. Use of sedatives and neuromuscular blockers in a cohort of patients receiving mechanical ventilation. Chest 2005; 128:496-506.
11. Arroliga AC, Thompson BT, Ancukiewicz M, et al. Use of sedatives, opioids, and neuromuscular blocking agents in patients with acute lung injury and acute respiratory distress syndrome. Crit Care Med 2008; 36:1083-1088.
12. Mehta S, Burry L, Fischer S, et al. Canadian survey of the use of sedatives, analgesics, and neuromuscular blocking agents in critically ill patients. Crit Care Med 2006; 34:374-380.
13. Ware LB, Matthay MA. The acute respiratory distress syndrome. N Engl J Med 2000; 342:1334-1349.
14. Hunter JM. New neuromuscular blocking drugs. N Engl J Med 1995; 332:1691-1699.
15. Mehta S, Granton J, MacDonald RJ, et al. High-frequency oscillatory ventilation in adults: the Toronto experience. Chest 2004; 126:518-527.
16. Sessler CN. Sedation, analgesia, and neuromuscular blockade for high-frequency oscillatory ventilation. Crit Care Med 2005; 33:S209-S216.
17. Westbrook PR, Stubbs SE, Sessler AD, et al. Effects of anesthesia and muscle paralysis on respiratory mechanics in normal man. J Appl Physiol 1973; 34:81-86.
18. Conti G, Vilardi V, Rocco M, et al. Paralysis has no effect on chest wall and respiratory system mechanics of mechanically ventilated, sedated patients. Intensive Care Med 1995; 21:808-812.
19. Sigurdsson S, Svantesson C, Larsson A, Jonson B. Elastic pressure-volume curves indicate derecruitment after a single deep expiration in anaesthetised and muscle-relaxed healthy man. Acta Anaesthesiol Scand 2000; 44:980-984.
20. Rehder K, Sessler AD, Rodarte JR. Regional intrapulmonary gas distribution in awake and anesthetized-paralyzed man. J Appl Physiol 1977; 42:391-402.
21. Tokics L, Hedenstierna G, Svensson L, et al. V/Q distribution and correlation to atelectasis in anesthetized paralyzed humans. J Appl Physiol 1996; 81:1822-1833.
22. Brismar B, Hedenstierna G, Lundquist H, et al. Pulmonary densities during anesthesia with muscular relaxation - a proposal of atelectasis. Anesthesiology 1985; 62:422-428.
23. Rothen HU, Sporre B, Engberg G, et al. Influence of gas composition on recurrence of atelectasis after a reexpansion maneuver during general anesthesia. Anesthesiology 1995; 82:832-842.
24. Krayer S, Rehder K, Vettermann J, et al. Position and motion of the human diaphragm during anesthesia-paralysis. Anesthesiology 1989; 70:891-898.
25. Neumann P, Rothen HU, Berglund JE, et al. Positive end-expiratory pressure prevents atelectasis during general anaesthesia even in the presence of a high inspired oxygen concentration. Acta Anaesthesiol Scand 1999; 43:295-301.
26. von Ungern-Sternberg BS, Hammer J, Schibler A, et al. Decrease of functional residual capacity and ventilation homogeneity after neuromuscular blockade in anesthetized young infants and preschool children. Anesthesiology 2006; 105:670-675.
27. Roch A, Forel FL, Blayac JM, et al. Neuromuscular blocking agents promote dependent lung consolidations in healthy ventilated lungs but not in injured lungs. Intensive Care Med 2007; 33:S80.
28. Pollitzer MJ, Reynolds EO, Shaw DG, Thomas RM. Pancuronium during mechanical ventilation speeds recovery of lungs of infants with hyaline membrane disease. Lancet 1981; 1:346-348.
29. Philips JB 3rd, Setzer ES, Drummond WH, et al. Hypoxaemia in ventilated neonates after pancuronium paralysis. Lancet 1979; 1:877.
30. Stark AR, Bascom R, Frantz ID 3rd. Muscle relaxation in mechanically ventilated infants. J Pediatr 1979; 94:439-443.
31. Crone RK, Favorito J. The effects of pancuronium bromide on infants with hyaline membrane disease. J Pediatr 1980; 97:991-993.
32. Bishop MJ. Hemodynamic and gas exchange effects of pancuronium bromide in sedated patients with respiratory failure. Anesthesiology 1984; 60:369-371.
33. Coggeshall JW, Marini JJ, Newman JH. Improved oxygenation after muscle relaxation in adult respiratory distress syndrome. Arch Intern Med 1985; 145:1718-1720.
34. Lagneau F, D'Honneur G, Plaud B, et al. A comparison of two depths of prolonged neuromuscular blockade induced by cisatracurium in mechanically ventilated critically ill patients. Intensive Care Med 2002; 28:1735-1741.
35. Gainnier M, Roch A, Forel JM, et al. Effect of neuromuscular blocking agents on gas exchange in patients presenting with acute respiratory distress syndrome. Crit Care Med 2004; 32:113-119.
36. Forel JM, Roch A, Marin V, et al. Neuromuscular blocking agents decrease inflammatory response in patients presenting with acute respiratory distress syndrome. Crit Care Med 2006; 34:2749-2757.
37. Leatherman JW, Fluegel WL, David WS, et al. Muscle weakness in mechanically ventilated patients with severe asthma. Am J Respir Crit Care Med 1996; 153:1686-1690.
38. Freebairn RC, Derrick J, Gomersall CD, et al. Oxygen delivery, oxygen consumption, and gastric intramucosal pH are not improved by a computer-controlled, closed-loop, vecuronium infusion in severe sepsis and septic shock. Crit Care Med 1997; 25:72-77.
39. Pinhu L, Whitehead T, Evans T, Griffiths M. Ventilator-associated lung injury. Lancet 2003; 361:332-340.
40. Tremblay LN, Slutsky AS. Ventilator-induced injury: from barotrauma to biotrauma. Proc Assoc Am Physicians 1998; 110:482-488.
41. Chiumello D, Pristine G, Slutsky AS. Mechanical ventilation affects local and systemic cytokines in an animal model of acute respiratory distress syndrome. Am J Respir Crit Care Med 1999; 160:109-116.
42. Tremblay L, Valenza F, Ribeiro SP, et al. Injurious ventilatory strategies increase cytokines and c-fos m-RNA expression in an isolated rat lung model. J Clin Invest 1997; 99:944-952.
43. Ranieri VM, Suter PM, Tortorella C, et al. Effect of mechanical ventilation on inflammatory mediators in patients with acute respiratory distress syndrome: a randomized controlled trial. JAMA 1999; 282:54-61.
44. Reynolds SF, Heffner J. Airway management of the critically ill patient: rapid-sequence intubation. Chest 2005; 127:1397-1412.
45. Orebaugh SL. Succinylcholine: adverse effects and alternatives in emergency medicine. Am J Emerg Med 1999; 17:715-721.
46. Booij LH. Is Succinylcholine appropriate or obsolete in the intensive care unit? Crit Care 2001; 5:245-246.
47. Perry JJ, Lee J, Wells G. Are intubation conditions using rocuronium equivalent to those using succinylcholine? Acad Emerg Med 2002; 9:813-823.
48. Levy BD, Kitch B, Fanta CH. Medical and ventilatory management of status asthmaticus. Intensive Care Med 1998; 24:105-117.
49. Latronico N, Peli E, Botteri M. Critical illness myopathy and neuropathy. Curr Opin Crit Care 2005; 11:126-132.
50. Latronico N, Guarneri B. Critical illness myopathy and neuropathy. Minerva Anestesiol 2008; 74:319-323.
51. Jackman RW, Kandarian SC. The molecular basis of skeletal muscle atrophy. Am J Physiol Cell Physiol 2004; 287:C834-C843.
52. Kindler CH, Verotta D, Gray AT, et al. Additive inhibition of nicotinic acetylcholine receptors by corticosteroids and the neuromuscular blocking drug vecuronium. Anesthesiology 2000; 92:821-832.
53. Testelmans D, Maes K, Wouters P, et al. Infusions of rocuronium and cisatracurium exert different effects on rat diaphragm function. Intensive Care Med 2007; 33:872-879.
54. Davis NA, Rodgers JE, Gonzalez ER, Fowler AA. Prolonged weakness after cisatracurium infusion: a case report. Crit Care Med 1998; 26:1290-1292.
55. De Jonghe B, Sharshar T, Lefaucheur JP, et al. Paresis acquired in the intensive care unit: a prospective multicenter study. JAMA 2002; 288:2859-2867.
56. Schweickert WD, Hall J. ICU-acquired weakness. Chest 2007; 131:1541-1549.
57. Bercker S, Weber-Carstens S, Deja M, et al. Critical illness polyneuropathy and myopathy in patients with acute respiratory distress syndrome. Crit Care Med 2005; 33:711-715.
58. Whetstone Foster JG, Clark AP. Functional recovery after neuromuscular blockade in mechanically ventilated critically ill patients. Heart Lung 2006; 35:178-189.
59. Errando CL, Sigl JC, Robles M, et al. Awareness with recall during general anaesthesia: a prospective observational evaluation of 4001 patients. Br J Anaesth 2008; 101:178-185.
60. Sandin RH, Enlund G, Samuelsson P, Lennmarken C. Awareness during anaesthesia: a prospective case study. Lancet 2000; 355:707-711.
61. Ballard N, Robley L, Barrett D, et al. Patients' recollections of therapeutic paralysis in the intensive care unit. Am J Crit Care 2006; 15:86-94.